Wolfgang Schueler

Title: Innovations of Wolfgang Schueler in the Field of Biotechnology

Introduction

Wolfgang Schueler is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for treating infections. With a total of 2 patents, his work has the potential to impact medical treatments and pharmaceutical compositions.

Latest Patents

Schueler's latest patents include groundbreaking inventions such as mutant fragments of outer surface protein A (OspA) and methods related to their use. The first patent focuses on a polypeptide comprising a mutant fragment of OspA, which is crucial for developing pharmaceutical compositions aimed at treating or preventing infections. The second patent involves isolated nucleic acid molecules that encode antigens from nontypable species, along with methods for producing these antigens and related antibodies. These inventions highlight his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Wolfgang Schueler is currently associated with Valneva Austria GmbH, where he continues to innovate in the biotechnology sector. His work at Valneva emphasizes the importance of research and development in creating effective treatments for bacterial infections.

Collaborations

Some of his notable coworkers include Markus Hanner and Andreas Meinke, who contribute to the collaborative environment that fosters innovation at Valneva. Their combined expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Wolfgang Schueler's contributions to biotechnology through his patents and collaborative efforts exemplify the spirit of innovation in medical science. His work not only addresses current health challenges but also paves the way for future advancements in treatment methodologies.